Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher Kelsey, MD
Duke Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospital Motol
Prague, Czechia
- University of Torino
Torino, Italy
- Juntendo University
Tokyo, Japan
- National Cancer Center of Singapore
Singapore, Singapore
- Yonsei University Health System
Seoul, South Korea
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Dana-Farber/brigham and Women'S Cancer Center in Clinical Affiliation With South Shore Hospital
Weymouth, Massachusetts, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- University of Rochester James P. Wilmot Cancer Institute
Rochester, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Feb 2019
- Primary completion
- 10 Jul 2025
- Completion
- 31 Jul 2028
- Last update posted
- 7 Jul 2026
- Registered enrollment
- 243
- Registry id
- NCT03681535
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.